Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic Fields

2017 · Mixed · Low evidence

← Research stream
MixedLow evidencePaper 2337

Across eight cell types, ELF-MF exposure increased ERK1/2 phosphorylation; p38 MAPK was very slightly phosphorylated, while JNK and Akt were not. ERK1/2 phosphorylation was detected at field strengths as low as 0.15 µT and was maximal at approximately 10 µT; …

Study snapshot

Publicationmanual · 2017
Study typein_vitro
Reported directionMixed
Evidence ratingLow

Abstract

Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic Fields Kapri-Pardes E, Hanoch T, Maik-Rachline G, Murbach M, Bounds PL, Kuster N, Seger R. Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic Fields. Cell Physiol Biochem. 2017 Oct 16;43(4):1. doi: 10.1159/000481977. Abstract BACKGROUND/AIMS: Results from recent studies suggest that extremely low frequency magnetic fields (ELF-MF) interfere with intracellular signaling pathways related to proliferative control. The mitogen-activated protein kinases (MAPKs), central signaling components that regulate essentially all stimulated cellular processes, include the extracellular signal-regulated kinases 1/2 (ERK1/2) that are extremely sensitive to extracellular cues. Anti- phospho-ERK antibodies serve as a readout for ERK1/2 activation and are able to detect minute changes in ERK stimulation. The objective of this study was to explore whether activation of ERK1/2 and other signaling cascades can be used as a readout for responses of a variety of cell types, both transformed and non- transformed, to ELF-MF. METHODS: We applied ELF-MF at various field strengths and time periods to eight different cell types with an exposure system housed in a tissue culture incubator and followed the phosphorylation of MAPKs and Akt by western blotting. RESULTS: We found that the phosphorylation of ERK1/2 is increased in response to ELF-MF. However, the phosphorylation of ERK1/2 is likely too low to induce ELF-MF-dependent proliferation or oncogenic transformation. The p38 MAPK was very slightly phosphorylated, but JNK or Akt were not. The effect on ERK1/2 was detected for exposures to ELF-MF strengths as low as 0.15 µT and was maximal at ∼10 µT. We also show that ERK1/2 phosphorylation is blocked by the flavoprotein inhibitor diphenyleneiodonium, indicating that the response to ELF-MF may be exerted via NADP oxidase similar to the phosphorylation of ERK1/2 in response to microwave radiation. CONCLUSIONS: Our results further indicate that cells are responsive to ELF-MF at field strengths much lower than previously suspected and that the effect may be mediated by NADP oxidase. However, the small increase in ERK1/2 phosphorylation is probably insufficient to affect proliferation and oncogenic transformation. Therefore, the results cannot be regarded as proof of the involvement of ELF-MF in cancer in general or childhood leukemia in particular. ncbi.nlm.nih.gov

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typein_vitro
Effect directionmixed
PopulationEight different cell types (transformed and non-transformed)
Sample sizeNot supplied
ExposureELF · various time periods
Evidence strengthLowConfidence: 74% · Peer reviewed: yes

Main findings

Across eight cell types, ELF-MF exposure increased ERK1/2 phosphorylation; p38 MAPK was very slightly phosphorylated, while JNK and Akt were not. ERK1/2 phosphorylation was detected at field strengths as low as 0.15 µT and was maximal at approximately 10 µT; the ERK1/2 response was blocked by diphenyleneiodonium, suggesting involvement of NADP oxidase. The authors state the ERK1/2 increase is likely too small to induce ELF-MF-dependent proliferation or oncogenic transformation and is not proof of involvement of ELF-MF in cancer or childhood leukemia.

Outcomes measured

  • ERK1/2 phosphorylation
  • p38 MAPK phosphorylation
  • JNK phosphorylation
  • Akt phosphorylation
  • Cell proliferation (inference/assessment)
  • Oncogenic transformation (inference/assessment)
  • Effect of diphenyleneiodonium (flavoprotein inhibitor) on ERK1/2 phosphorylation

Limitations

  • Frequency of ELF-MF not specified in the abstract
  • Sample sizes/replicates not reported in the abstract
  • Proliferation/oncogenic transformation were not demonstrated; conclusions about these outcomes are based on the magnitude of signaling changes
View raw extracted JSON
{
  "study_type": "in_vitro",
  "exposure": {
    "band": "ELF",
    "source": null,
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": "various time periods"
  },
  "population": "Eight different cell types (transformed and non-transformed)",
  "sample_size": null,
  "outcomes": [
    "ERK1/2 phosphorylation",
    "p38 MAPK phosphorylation",
    "JNK phosphorylation",
    "Akt phosphorylation",
    "Cell proliferation (inference/assessment)",
    "Oncogenic transformation (inference/assessment)",
    "Effect of diphenyleneiodonium (flavoprotein inhibitor) on ERK1/2 phosphorylation"
  ],
  "main_findings": "Across eight cell types, ELF-MF exposure increased ERK1/2 phosphorylation; p38 MAPK was very slightly phosphorylated, while JNK and Akt were not. ERK1/2 phosphorylation was detected at field strengths as low as 0.15 µT and was maximal at approximately 10 µT; the ERK1/2 response was blocked by diphenyleneiodonium, suggesting involvement of NADP oxidase. The authors state the ERK1/2 increase is likely too small to induce ELF-MF-dependent proliferation or oncogenic transformation and is not proof of involvement of ELF-MF in cancer or childhood leukemia.",
  "effect_direction": "mixed",
  "limitations": [
    "Frequency of ELF-MF not specified in the abstract",
    "Sample sizes/replicates not reported in the abstract",
    "Proliferation/oncogenic transformation were not demonstrated; conclusions about these outcomes are based on the magnitude of signaling changes"
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "extremely low frequency magnetic fields",
    "ELF-MF",
    "MAPK",
    "ERK1/2",
    "p38",
    "JNK",
    "Akt",
    "phosphorylation",
    "western blot",
    "NADP oxidase",
    "diphenyleneiodonium",
    "cell signaling"
  ],
  "suggested_hubs": [
    {
      "slug": "occupational-exposure",
      "weight": 0.2,
      "reason": "Study examines ELF magnetic-field strengths in the µT range, which can be relevant to occupational ELF exposures, though no specific source is described."
    }
  ]
}
AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.1159/000481977
PubMed: Not supplied

Read the original paper →

Related papers

← Back to the Research Library